RICI HEALTHCARE HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.23 HKD | +0.82% |
|
+3.36% | +5.13% |
| Mar. 28 | Rici Healthcare Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 11 | Rici Healthcare’s Profit Forecast to Rise in 2023; Shares Up 3% | MT |
| Sales 2022 | 2.38B 328M 2.56B | Sales 2023 | 2.99B 413M 3.23B | Capitalization | 1.69B 234M 1.83B |
|---|---|---|---|---|---|
| Net income 2022 | 291M 40.19M 314M | Net income 2023 | 364M 50.27M 393M | EV / Sales 2022 | 0.97 x |
| Net Debt 2022 | 1.58B 218M 1.7B | Net Debt 2023 | 1.46B 201M 1.57B | EV / Sales 2023 | 1.05 x |
| P/E ratio 2022 |
2.51
x | P/E ratio 2023 |
4.65
x | Employees | 9,413 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.72% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.82% | ||
| 1 week | +3.36% | ||
| 1 month | +8.85% | ||
| 3 months | +6.96% | ||
| 6 months | -0.81% | ||
| Current year | +5.13% |
1 week
1.17
1.23
1 month
1.101.23
Current year
1.011.24
1 year
0.561.35
3 years
0.361.70
5 years
0.361.77
10 years
0.362.66
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Xin Fang
CEO | Chief Executive Officer | 59 | 16-02-02 |
Xiao Ying Lin
COO | Chief Operating Officer | 46 | - |
Hao Ze Fang
BRD | Director/Board Member | 35 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pei Xing Jiang
BRD | Director/Board Member | 56 | 17-06-05 |
Sze Wing Wong
BRD | Director/Board Member | 46 | 16-06-22 |
Yong Wang
BRD | Director/Board Member | 58 | 16-06-22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 1.23 | +0.82% | 172,000 |
| 24-05-30 | 1.22 | +0.83% | 97,000 |
| 24-05-29 | 1.21 | -.--% | 16,000 |
| 24-05-28 | 1.21 | -.--% | 46,000 |
| 24-05-27 | 1.21 | +1.68% | 203,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotes
Rici Healthcare Holdings Ltd is a China-based holding company that mainly engages in medical examination services. The Company operates two segments. General Hospital segment provides general hospital services and confinement services. Medical Examination Centres segment provides medical examination services. The general hospital services provide online and offline services before, during and after the diagnosis, including cardiovascular surgery, orthopedics, general surgery, thoracic surgery, and others. The medical examination services include ultrasound, imaging, testing, main examination, and others. The Company operates primarily in China.
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.13% | 250M | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -5.56% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +79.20% | 13.21B | |
| +70.11% | 13.08B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- 1526 Stock
